| Aktier | 585,248 Mrd | — | KO KoAct | 0 | Hälsovård | | 2023-08-03 | 21 596,8 | 8,05 | 37,04 |
KO | Aktier | 286,374 Mrd | — | KO KODEX | 0,45 | Hälsovård | FnGuide Bio Index - Benchmark TR Gross | 2016-05-13 | 11 865,53 | 5,44 | 37,93 |
TE | Aktier | 265,194 Mrd | — | TE Tiger ETF | 0,4 | Hälsovård | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 2020-10-06 | 8 021,07 | 6,03 | 51,44 |
TE | Aktier | 189,277 Mrd | — | TE Tiger ETF | 0,4 | Hälsovård | KRX Healthcare - KRW | 2011-07-15 | 46 695,71 | 4,63 | 39,62 |
TE | Aktier | 97,468 Mrd | — | TE Tiger ETF | 0,3 | Hälsovård | NASDAQ / Biotechnology | 2014-08-26 | 31 635,63 | 4,88 | 21,01 |
KO | Aktier | 94,881 Mrd | — | KO KODEX | 0,09 | Hälsovård | KRX Healthcare - KRW | 2017-03-28 | 21 243,97 | 4,63 | 39,65 |
TE | Aktier | 74,278 Mrd | — | TE Tiger ETF | 0,4 | Hälsovård | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 2016-12-14 | 18 235,61 | 10,44 | 59,1 |
| Aktier | 71,702 Mrd | — | KR KB RISE | 0 | Hälsovård | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 2024-12-24 | 15 679,68 | 9,56 | 68,04 |
TE | Aktier | 64,212 Mrd | — | TE Tiger ETF | 0,49 | Hälsovård | Solactive China Biotech Index | 2020-12-03 | 8 968,25 | 4,03 | 28,69 |
KO | Aktier | 61,401 Mrd | — | KO KODEX | 0,25 | Hälsovård | S&P Health Care Select Sector | 2023-03-21 | 13 619,17 | 4,86 | 22,5 |
TE | Aktier | 44,498 Mrd | — | TE Tiger ETF | 0,45 | Hälsovård | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 2024-02-29 | 10 059,99 | 7,96 | 17,83 |
KO | Aktier | 42,664 Mrd | — | KO KODEX | 0,45 | Hälsovård | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 2024-02-14 | 10 794,98 | 5,08 | 12,43 |
SP | Aktier | 38,413 Mrd | 15,229 M | SP SPDR | 0,08 | Hälsovård | S&P Health Care Select Sector | 1998-12-16 | 143,29 | 4,86 | 22,63 |
TE | Aktier | 31,309 Mrd | — | TE Tiger ETF | 0 | Hälsovård | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 2016-06-29 | 25 608,61 | 0 | 0 |
TE | Aktier | 31,058 Mrd | — | TE Tiger ETF | 0,4 | Hälsovård | KOSPI 200 Health Care Index - KRW | 2015-09-23 | 20 822,89 | 2,91 | 30,55 |
| Aktier | 28,453 Mrd | — | HW Hwabao | 0,6 | Hälsovård | CSI Medical Index Yield - Benchmark TR Gross | 2019-05-20 | 0,34 | 3,08 | 30,88 |
KO | Aktier | 21,423 Mrd | — | KO KODEX | 0,25 | Hälsovård | S&P Biotechnology Select Industry | 2013-10-31 | 41 813,56 | 0 | 0 |
EF | Aktier | 17,417 Mrd | — | EF E Fund | 0 | Hälsovård | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 2021-01-09 | 0,37 | 3,4 | 26,67 |
VA | Aktier | 16,498 Mrd | 231 887,9 | VA Vanguard | 0,09 | Hälsovård | MSCI US IMI 25/50 Health Care | 2004-01-26 | 272,55 | 5,01 | 23,09 |
NH | Aktier | 15,996 Mrd | — | NH NH-Amundi | 0 | Hälsovård | | 2024-11-26 | 14 892,57 | 5 | 44,18 |
| Aktier | 14,213 Mrd | — | KO KoAct | 0,5 | Hälsovård | | 2025-11-11 | 10 338,06 | 5,59 | 22,65 |
| Aktier | 12,596 Mrd | — | KR KB RISE | 0 | Hälsovård | FnGuide HealthCare Index - KRW - Benchmark TR Net | 2016-09-23 | 16 773,64 | 4,73 | 37,18 |
| Aktier | 9,163 Mrd | — | AC ACE | 0,3 | Hälsovård | Solactive Global Big Pharma Index - Benchmark Price Return | 2024-11-19 | 12 860,55 | 7,21 | 21,79 |
KI | Aktier | 8,411 Mrd | — | KI Kiwoom | 0,49 | Hälsovård | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 2024-05-28 | 12 779,55 | 0 | 0 |
IS | Aktier | 8,227 Mrd | 1,762 M | IS iShares | 0,44 | Hälsovård | NYSE Biotechnology (TR) | 2001-02-05 | 169,45 | 5,1 | 21,9 |
| Aktier | 8,18 Mrd | — | AC ACE | 0,45 | Hälsovård | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 2024-11-19 | 12 381,65 | 3,6 | 21,75 |
| Aktier | 7,941 Mrd | — | KO KoAct | 0 | Hälsovård | | 2026-01-27 | 10 133,67 | 4,34 | 29,64 |
SP | Aktier | 7,494 Mrd | 9,357 M | SP SPDR | 0,35 | Hälsovård | S&P Biotechnology Select Industry | 2006-01-31 | 119,59 | 5,08 | 0 |
| Aktier | 6,848 Mrd | — | KO KoAct | 0,5 | Hälsovård | | 2024-09-03 | 12 841,88 | 4,21 | 17,95 |
BO | Aktier | 6,662 Mrd | — | BO Bosera | 0,65 | Hälsovård | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 2021-03-18 | 0,61 | 2,75 | 12,8 |
CH | Aktier | 6,371 Mrd | — | CH ChinaAMC | 0,65 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-09-29 | 0,82 | 3 | 21,32 |
TE | Aktier | 6,279 Mrd | — | TE Tiger ETF | 0,5 | Hälsovård | FnGuide Medical Device Index - KRX - Benchmark TR Net | 2018-11-07 | 17 612,46 | 2,77 | 23,45 |
KI | Aktier | 5,925 Mrd | — | KI Kiwoom | 0,49 | Hälsovård | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 2024-05-28 | 11 652,44 | 4,37 | 17,87 |
| Aktier | 5,693 Mrd | — | MA Maxwealth | 0,6 | Hälsovård | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 2021-04-22 | 0,49 | 2,64 | 31,06 |
| Aktier | 5,441 Mrd | — | NI Nippon | 0,19 | Hälsovård | Nifty Pharma Index - INR - Benchmark TR Gross | 2021-07-02 | 17,49 | 4,59 | 31,47 |
NF | Aktier | 5,437 Mrd | — | NF NEXT FUNDS | 0,32 | Hälsovård | | 2008-03-21 | 33 088,93 | 1,86 | 21,64 |
| Aktier | 5,154 Mrd | — | KR KB RISE | 0,35 | Hälsovård | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 2024-02-27 | 9 602,93 | 7,72 | 19,09 |
TE | Aktier | 4,915 Mrd | — | TE Tiger ETF | 0,4 | Hälsovård | TOPIX-17 PHARMACEUTICAL - JPY | 2016-06-29 | 12 065 | 0 | 0 |
IN | Aktier | 4,859 Mrd | — | IN Invesco | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2024-10-16 | 1,69 | 3,45 | 24,62 |
IC | Aktier | 4,738 Mrd | — | IC ICBC | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-03-26 | 1,24 | 0 | 0 |
EF | Aktier | 4,018 Mrd | — | EF E Fund | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-03-18 | 1,18 | 0 | 0 |
GU | Aktier | 3,732 Mrd | — | GU Guotai | 0,6 | Hälsovård | CSI Biomedical Index - CNY - Benchmark TR Gross | 2019-04-18 | 1 | 0 | 0 |
IS | Aktier | 3,642 Mrd | 227 363,2 | IS iShares | 0,4 | Hälsovård | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 2001-11-13 | 93,91 | 4,19 | 21,81 |
XT | Aktier | 3,236 Mrd | — | XT Xtrackers | 0,25 | Hälsovård | MSCI World Index / Health Care -SEC | 2010-11-22 | 55,43 | 4,44 | 21,81 |
IS | Aktier | 3,221 Mrd | 2,437 M | IS iShares | 0,38 | Hälsovård | DJ US Select / Medical Equipment | 2006-05-01 | 53,23 | 3,79 | 29,41 |
FU | Aktier | 3,148 Mrd | — | FU Fullgoal | 0,6 | Hälsovård | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 2023-06-14 | 1,44 | 0 | 0 |
IS | Aktier | 2,906 Mrd | 903 150,2 | IS iShares | 0,38 | Hälsovård | Russell 1000 Health Care RIC 22.5/45 Capped Index | 2000-06-12 | 61,66 | 4,86 | 22,76 |
FI | Aktier | 2,823 Mrd | 189 727,8 | FI Fidelity | 0,08 | Hälsovård | MSCI US IMI 25/50 Health Care | 2013-10-21 | 70,53 | 4,77 | 22,64 |
NH | Aktier | 2,735 Mrd | — | NH NH-Amundi | 0,45 | Hälsovård | iSelect K-MediTech Index - KRW - Benchmark Price Return | 2023-12-21 | 9 115,65 | 3,43 | 26,31 |
IS | Aktier | 2,548 Mrd | — | IS iShares | 0,15 | Hälsovård | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 2015-11-20 | 11,8 | 4,86 | 22,63 |
| Aktier | 2,455 Mrd | — | HW Hwabao | 0 | Hälsovård | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 Mrd | 0 | 0 |
GU | Aktier | 2,304 Mrd | — | GU Guotai | 0,6 | Hälsovård | CSI Medical Index Yield - Benchmark TR Gross | 2020-12-24 | 0,42 | 3,08 | 30,9 |
FT | Aktier | 2,289 Mrd | 62 733,24 | FT First Trust | 0,54 | Hälsovård | NYSE Arca Biotechnology Index | 2006-06-19 | 202,01 | 3,45 | 22,71 |
CH | Aktier | 2,209 Mrd | — | CH ChinaAMC | 0,75 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-03-18 | 15,76 | 3,09 | 22,35 |
CH | Aktier | 2,209 Mrd | — | CH ChinaAMC | 0,75 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-03-18 | 15,76 | 3,09 | 22,35 |
PA | Aktier | 1,819 Mrd | — | PA Ping An | 0,6 | Hälsovård | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 2021-06-09 | 0,36 | 4,13 | 25,07 |
EF | Aktier | 1,618 Mrd | — | EF E Fund | 0,2 | Hälsovård | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 2022-01-19 | 1,11 | 2,5 | 20,25 |
HE | Aktier | 1,614 Mrd | — | HE Harvest ETFs | 1,06 | Hälsovård | | 2014-11-19 | 7,11 | 5,01 | 23,83 |
AM | Aktier | 1,49 Mrd | — | AM Amundi | 0,5 | Hälsovård | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 2022-06-08 | 9 937,75 | 2,82 | 14,76 |
EF | Aktier | 1,448 Mrd | — | EF E Fund | 0,2 | Hälsovård | China Securities Medical Index - CNY - Benchmark TR Gross | 2021-07-08 | 0,4 | 4,4 | 29,55 |
EF | Aktier | 1,435 Mrd | — | EF E Fund | 0,2 | Hälsovård | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 2021-01-14 | 0,5 | 2,8 | 29,2 |
IS | Aktier | 1,417 Mrd | — | IS iShares | 0,18 | Hälsovård | MSCI Europe Health Care 20/35 Capped Index - EUR | 2020-11-17 | 7,11 | 3,73 | 19,22 |
CA | Aktier | 1,391 Mrd | — | CA Cathay | 1,05 | Hälsovård | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 2021-11-22 | 8,22 | 3,39 | 17,66 |
IS | Aktier | 1,361 Mrd | — | IS iShares | 0,46 | Hälsovård | S&P Global 1200 Healthcare Sector Index - AUD | 2001-11-13 | 135,07 | 0 | 0 |
EF | Aktier | 1,323 Mrd | — | EF E Fund | 0,2 | Hälsovård | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 2021-02-03 | 0,68 | 3,14 | 28,62 |
GU | Aktier | 1,314 Mrd | — | GU Guotai | 0,6 | Hälsovård | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 2025-08-01 | 0,95 | 0 | 0 |
HA | Aktier | 1,129 Mrd | — | HA Harvest | 0,6 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-07-30 | 0,91 | 0 | 0 |
XT | Aktier | 1,116 Mrd | — | XT Xtrackers | 0,12 | Hälsovård | MSCI USA / Health Care -SEC | 2017-09-12 | 58,78 | 5,07 | 22,81 |
XT | Aktier | 1,116 Mrd | — | XT Xtrackers | 0,12 | Hälsovård | MSCI USA / Health Care -SEC | 2017-09-12 | 58,78 | 5,07 | 22,81 |
VA | Aktier | 1,05 Mrd | 433 579,7 | VA VanEck | 0,36 | Hälsovård | MVIS US Listed Pharmaceutical 25 | 2011-12-20 | 104,17 | 4,92 | 18,95 |
IS | Aktier | 1,008 Mrd | 86 576,5 | IS iShares | 0,38 | Hälsovård | DJ US Select / Pharmaceutical | 2006-05-01 | 86,97 | 4,59 | 21,41 |
IS | Aktier | 1,001 Mrd | — | IS iShares | 0,4 | Hälsovård | STOXX Global Breakthrough Healthcare (USD)(NR) | 2016-09-08 | 8,73 | 3,82 | 20,92 |
IS | Aktier | 1,001 Mrd | — | IS iShares | 0,4 | Hälsovård | STOXX Global Breakthrough Healthcare (USD)(NR) | 2016-09-08 | 8,73 | 3,82 | 20,92 |
GX | Aktier | 977,457 M | — | GX Global X | 0,59 | Hälsovård | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 2021-06-21 | 1 739,46 | 1,9 | 19,17 |
CS | Aktier | 926,443 M | — | CS CSOP | 1,5 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-07-21 | 3,75 | 3,33 | 23,96 |
| Aktier | 897,705 M | — | WA Wanjia | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2024-09-13 | 1,62 | 3,45 | 24,62 |
IS | Aktier | 882,603 M | — | IS iShares | 0,35 | Hälsovård | NASDAQ / Biotechnology | 2017-10-19 | 8,52 | 0 | 0 |
FT | Aktier | 851,151 M | 27 073,22 | FT First Trust | 0,61 | Hälsovård | StrataQuant Health Care Index | 2007-05-08 | 110,48 | 3,02 | 17,23 |
AM | Aktier | 827,261 M | — | AM Amundi | 0,3 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2019-01-17 | 150,86 | 2,85 | 19,76 |
AM | Aktier | 827,261 M | — | AM Amundi | 0,3 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2019-01-17 | 150,86 | 2,85 | 19,76 |
| Aktier | 742,094 M | 103 248,7 | PB Portfolio Building Block | 0,13 | Hälsovård | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 2025-11-24 | 25,55 | 4,93 | 20,32 |
CA | Aktier | 721,535 M | — | CA Cathay | 0,41 | Hälsovård | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 2019-04-23 | 30,05 | 0 | 0 |
IS | Aktier | 706,186 M | — | IS iShares | 0,46 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2001-04-25 | 113,57 | 3,63 | 19,15 |
IN | Aktier | 703,768 M | 66 288,5 | IN Invesco | 0,4 | Hälsovård | S&P 500 Equal Weighted / Health Care -SEC | 2006-11-01 | 30,28 | 3,04 | 19,91 |
AM | Aktier | 699,02 M | — | AM Amundi | 0,3 | Hälsovård | MSCI World Index / Health Care -SEC | 2010-08-19 | 469,06 | 7,68 | 29,88 |
IS | Aktier | 670,635 M | 260 406,8 | IS iShares | 0,38 | Hälsovård | DJ US Select / Health Care Providers | 2006-05-01 | 42,48 | 2,3 | 16,34 |
GX | Aktier | 626,554 M | — | GX Global X | 0,68 | Hälsovård | Solactive China Biotech Index | 2019-07-25 | 72,23 | 4,18 | 30,21 |
GX | Aktier | 626,554 M | — | GX Global X | 0,68 | Hälsovård | Solactive China Biotech Index | 2019-07-25 | 72,23 | 4,18 | 30,21 |
CS | Aktier | 615,176 M | — | CS China Southern | 0,65 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 2022-06-17 | 1,1 | 2,98 | 21,35 |
SP | Aktier | 604,293 M | — | SP SPDR | 0,3 | Hälsovård | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 2016-04-29 | 63,22 | 4,44 | 21,81 |
IS | Aktier | 598,291 M | — | IS iShares | 0,18 | Hälsovård | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 2019-10-17 | 7,46 | 4,16 | 22,04 |
SP | Aktier | 573,552 M | — | SP SPDR | 0,18 | Hälsovård | MSCI Europe Health Care Index - EUR | 2014-12-05 | 218,89 | 3,73 | 19,22 |
SP | Aktier | 537,261 M | — | SP SPDR | 0,15 | Hälsovård | S&P Health Care Select Sector Daily Capped 25/20 Index | 2015-07-07 | 45,19 | 4,86 | 22,63 |
FU | Aktier | 532,215 M | — | FU Fullgoal | 0,6 | Hälsovård | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 2020-03-16 | 0,94 | 0 | 0 |
GU | Aktier | 508,014 M | — | GU Guotai | 0,6 | Hälsovård | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 2021-09-08 | 0,75 | 3,53 | 27,58 |
DI | Aktier | 504,181 M | 615 495,5 | DI Direxion | 0,96 | Hälsovård | S&P Biotechnology Select Industry | 2015-05-28 | 171,39 | 0 | 0 |
IS | Aktier | 494,936 M | — | IS iShares | 0,66 | Hälsovård | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 2011-04-12 | 66,05 | 0 | 0 |
CH | Aktier | 489,926 M | — | CH ChinaAMC | 0,6 | Hälsovård | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 2023-11-23 | 0,83 | 2,64 | 31,04 |
CS | Aktier | 416,909 M | — | CS China Southern | 0,2 | Hälsovård | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 2021-03-12 | 0,65 | 3,14 | 28,61 |
IN | Aktier | 413,365 M | — | IN Invesco | 0,4 | Hälsovård | NASDAQ / Biotechnology | 2014-11-06 | 59,52 | 4,94 | 21,49 |